PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Boosting the immune system to treat brain cancer

Researchers identify mechanism implicated in brain cancer and a drug that decreases brain tumor growth

2013-12-09
(Press-News.org) Contact information: Marta
mcyperli@ucalgary.ca
403-210-3835
University of Calgary
Boosting the immune system to treat brain cancer Researchers identify mechanism implicated in brain cancer and a drug that decreases brain tumor growth Researchers at the University of Calgary's Hotchkiss Brain Institute (HBI) have made a discovery that could lead to better treatment for patients suffering from brain cancer.

Despite current treatment strategies, the median survival for patients with the most aggressive brain cancer – called glioblastoma, is 15 months. Less than five per cent of patients survive beyond five years.

HBI member V. Wee Yong, PhD and research associate Susobhan Sarkar, PhD, and their team including researchers from the Department of Clinical Neurosciences and the university's Southern Alberta Cancer Research Institute, looked at human brain tumour samples and discovered that specialized immune cells in brain tumour patients are compromised. The researchers took this discovery and, in an animal model, identified a drug that is able to re-activate those immune cells and reduce brain tumour growth, thereby increasing the lifespan of mice two to three times. Their discovery will be published December 8th in the prestigious journal Nature Neuroscience.

Our brains normally contain specialized cells, called microglia, that defend against injury or infection. "Microglia are the brain's own dedicated immune system," explains Yong. "And in this study, we have formally demonstrated for the first time that these cells are compromised in living brain tumour patients."

As with other forms of cancer, brain tumours start as individual stem-like cells – called brain tumour initiating cells (BTICs). These cells quickly divide and grow, eventually forming a mass, or tumour. Yong and his team have discovered that the tumour disables microglia, permitting the rapid proliferation of BTICs, which ultimately leads to brain tumour growth.

"We refer to this as the battle for the brain, in which early on in the disease, the microglia are trying to destroy the brain tumour initiating cells," says Yong. "But over the course of time, the tumour disables the microglia and we start to see more initiating cells and more rapid tumour growth. We have sought to tip the battle in favour of the brain to suppress the tumour."

In addition to discovering this mechanism, Yong and Sarkar also identified a drug - amphotericin B (AmpB) - to reactivate microglia that in an animal model, showed a significant reduction in brain tumour growth.

"This drug was able to re-activate the disabled microglia," says Sarkar, "thus restoring the body's natural defense mechanisms and restricting the growth of brain tumour initiating cells." The drug they identified is a powerful agent that is already used clinically to treat severe fungal infections of the brain and spinal cord. "It's a rather harsh medication," says Yong. "But we have demonstrated that this drug can be used in very small doses where it is not only well tolerated, but it is also effective in re-programming microglia."

Yong and Sarkar hope this discovery will lead to clinical trials and ultimately to a new standard of care for brain tumour patients.

The finding has already garnered attention from researchers across Canada, including internationally recognized brain tumour scientist and neurosurgeon Dr. James Rutka.

"This research is highly significant as it implies that a commercially available drug, amphotericin B, which has never been used before for patients with gliomas, may be a novel treatment to consider in future trials of patients with this frequently lethal cancer," says Dr. Rutka, Professor and Chair, Department of Surgery, University of Toronto.

### The funding was provided by Alberta Innovates – Health Solutions/Alberta Cancer Foundation. V. Wee Yong is a Canada Research Chair in Neuroimmunology.


ELSE PRESS RELEASES FROM THIS DATE:

Extensive variability in olfactory receptors influences human odor perception

2013-12-09
Extensive variability in olfactory receptors influences human odor perception We each live in a unique odor world PHILADELPHIA (December 8, 2013) – According to Gertrude Stein, "A rose is a rose is a rose," but new research indicates that might not be the case ...

New rearing method may help control of the western bean cutworm

2013-12-09
New rearing method may help control of the western bean cutworm The western bean cutworm is a destructive insect pest of dry beans and corn. Inadequate protocols for laboratory rearing of this insect have hindered controlled efficacy experimentation ...

The invasive Turkestan cockroach is displacing the oriental cockroach in the southwestern US

2013-12-09
The invasive Turkestan cockroach is displacing the oriental cockroach in the southwestern US The Turkestan cockroach, Blatta lateralis (Walker), has become an important invasive species throughout the southwestern United States and has been reported ...

Electrical control of single atom magnets

2013-12-09
Electrical control of single atom magnets The energy needed to change the magnetic orientation of a single atom – which determines its magnetic stability and therefore its usefulness in a variety of future device applications – can be modified by varying the ...

Surprising diversity in aging revealed in nature

2013-12-09
Surprising diversity in aging revealed in nature In our youth we are strong and healthy and then we weaken and die - that's probably how most would describe what ageing is all about. But, in nature, the phenomenon of ageing shows an unexpected diversity of patterns and ...

Concussion secrets unveiled in mice and people

2013-12-09
Concussion secrets unveiled in mice and people NIH scientists film early concussion damage and describe brain's response to injury There is more than meets the eye following even a mild traumatic brain injury. While ...

How can we improve the efficacy of antipsychotics in the era of personalized pharmacotherapy?

2013-12-09
How can we improve the efficacy of antipsychotics in the era of personalized pharmacotherapy? 2 pharmacists from UdeM and the Institut universitaire en sante mentale de Montreal give us some answers This news release is available in French. The ...

Peer-review science is taking off on Twitter, but who is tweeting what and why?

2013-12-09
Peer-review science is taking off on Twitter, but who is tweeting what and why? The most tweeted peer-reviewed articles published between 2010 and 2012, and the trends associated with their social media success, have been identified by Stefanie ...

High chair-related injuries to children on the rise

2013-12-09
High chair-related injuries to children on the rise Every hour, every day a child is taken to a hospital as injuries surge 22 percent (COLUMBUS, Ohio) – High chairs and booster seats are commonly used to help make feeding young children ...

Innovative drug-dispensing contact lens delivers glaucoma medication continuously for a month

2013-12-09
Innovative drug-dispensing contact lens delivers glaucoma medication continuously for a month Biomaterials features findings of Mass. Eye and Ear, Harvard Medical School study BOSTON (Dec. 9, 2013) – For nearly half a century, contact lenses have ...

LAST 30 PRESS RELEASES:

The most effective diabetes drugs don't reach enough patients yet

Breast cancer risk in younger women may be influenced by hormone therapy

Strategies for staying smoke-free after rehab

Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy

Study projects over 14 million preventable deaths by 2030 if USAID defunding continues

New study reveals 33% gap in transplant access for UK’s poorest children

Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)

IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer

It takes a village: Chimpanzee babies do better when their moms have social connections

From lab to market: how renewable polymers could transform medicine

Striking increase in obesity observed among youth between 2011 and 2023

No evidence that medications trigger microscopic colitis in older adults

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

Groundbreaking analysis provides day-by-day insight into prehistoric plankton’s capacity for change

Southern Ocean saltier, hotter and losing ice fast as decades-long trend unexpectedly reverses

Human fishing reshaped Caribbean reef food webs, 7000-year old exposed fossilized reefs reveal

Killer whales, kind gestures: Orcas offer food to humans in the wild

Hurricane ecology research reveals critical vulnerabilities of coastal ecosystems

Montana State geologist’s Antarctic research focuses on accumulations of rare earth elements

Groundbreaking cancer therapy clinical trial with US Department of Energy’s accelerator-produced actinium-225 set to begin this summer

Tens of thousands of heart attacks and strokes could be avoided each year if cholesterol-lowering drugs were used according to guidelines

Leading cancer and metabolic disease expert Michael Karin joins Sanford Burnham Prebys

Low-intensity brain stimulation may restore neuron health in Alzheimer's disease

[Press-News.org] Boosting the immune system to treat brain cancer
Researchers identify mechanism implicated in brain cancer and a drug that decreases brain tumor growth